BioLine Rx
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Public
- Established
- 2003-01-01
- Employees
- 79
- Market Cap
- $59.2M
- Website
- http://www.biolinerx.com
- Introduction
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumor...
A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection
BioLineRx launches Mobilization Matters, a digital resource for multiple myeloma patients preparing for stem cell collection, in partnership with HealthTree Foundation. A survey to gather patient insights on stem cell collection experiences is underway, with results expected in Q1 2025.
© Copyright 2024. All Rights Reserved by MedPath